Prognostic Value of Metabolic Tumor Burden from 18F-FDG PET in Surgical Patients with Non–small-cell Lung Cancer
- 20 September 2012
- journal article
- Published by Elsevier BV in Academic Radiology
- Vol. 20 (1), 32-40
- https://doi.org/10.1016/j.acra.2012.07.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic Value of the Quantitative Metabolic Volumetric Measurement on 18F-FDG PET/CT in Stage IV Nonsurgical Small-cell Lung CancerAcademic Radiology, 2012
- Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapyActa Radiologica, 2011
- Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC)European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Fluorodeoxyglucose Uptake of Primary Non-Small Cell Lung Cancer at Positron Emission Tomography: New Contrary Data on Prognostic RoleClinical Cancer Research, 2007
- The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancerEuropean Journal Of Cancer, 2007
- Concordance probability and discriminatory power in proportional hazards regressionBiometrika, 2005
- Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer ResectionJournal of Clinical Oncology, 2004
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958